Latest Orica (ASX:ORI) News

Gold explorers and small-cap tech names drove the biggest share price swings this week, while one healthcare stock sank after a deeply discounted funding move. Deals, drill hits and fresh financing dominated trading across the ASX.

Gold stories drove the week, but the biggest jumps came from drill hits and project studies that gave investors a reason to chase smaller names. At the larger end, merger activity and fresh funding kept attention on producers that want to get bigger, faster.

Orica Limited posted its strongest half-year EBIT in over 20 years at $512 million, driven by premium product demand and strategic acquisitions including Nelson Brothers. The company also initiated a $100 million cost reduction program and declared a 28.5 cent interim dividend.

A brutal split opened up in small caps: a few stocks surged on hard approvals and funding, while many resource names slid even after announcing big numbers. The week’s tape looked simple: investors paid for certainty and sold anything that still needs time, permits, or more cash.

A brutal sell-off in a few small caps did most of the damage this week, even as project funding and resource upgrades kept rolling in. Lithium, rare earths and tungsten news stayed constructive, but traders punished anything that looked like delays, dilution or weaker prices.

Orica Limited has resolved its US litigation with CF Industries by agreeing to a US$169.5 million settlement and is acquiring Nelson Brothers’ explosives business, strengthening its North American operations and boosting earnings.

A single biotech result reset expectations in minutes, while gold and critical minerals kept investors busy on deals, drilling and funding. The week’s biggest moves came from one trial being stopped, a miner losing altitude after heavy selling, and a U.S. tungsten stock hit hard on risk-off trading.

Gold names split cleanly this week: one stock rocketed on tangible production progress, while another cratered as selling overwhelmed a big plan. Critical minerals kept drawing attention, but several gap-ups didn’t hold once early buyers took profits.

Orica reports solid first-half earnings growth led by digital and specialty chemicals, while launching a $100 million cost reduction program to navigate supply disruptions and litigation headwinds.

Orica Limited has delivered its strongest financial performance in over a decade, driven by premium product demand and digital innovation, while advancing ambitious sustainability targets. The company signals continued growth for 2026 despite emerging supply chain challenges.

Orica Limited has reported its strongest earnings in over a decade, with a 23% rise in EBIT to $992 million and a 32% jump in net profit before significant items. The company also increased its share buy-back program and declared a higher dividend, signaling confidence in its growth strategy and sustainability commitments.

Orica Limited reported a 6% increase in revenue to AUD 8.14 billion and a 23% rise in EBIT to AUD 992.2 million for FY2025, alongside record safety performance and significant strides in decarbonisation.